Effects of autologous platelet transfusion on platelet inhibition in ticagrelor-treated and clopidogrel-treated subjects
Author:
Affiliation:
1. AstraZeneca LP; Gaithersburg MD USA
2. AstraZeneca; Gothenberg Sweden
Funder
AstraZeneca
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13511/fullpdf
Reference46 articles.
1. Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist;Husted;Cardiovasc Ther,2009
2. Ticagrelor binds to human P2Y(12) independently from ADP but antagonizes ADP-induced receptor signaling and PA;Giezen;J Thromb Haemost,2009
3. Characterization of the adenosine pharmacology of ticagrelor reveals therapeutically relevant inhibition of equilibrative nucleoside transporter 1;Armstrong;J Cardiovasc Pharmacol Ther,2014
4. Adenosine-mediated effects of ticagrelor: evidence and potential clinical relevance;Cattaneo;J Am Coll Cardiol,2014
5. Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y(12) receptor antagonist, in healthy subjects;Teng;Eur J Clin Pharmacol,2010
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ticagrelor Versus Clopidogrel in Endovascular Therapy for Cerebral Aneurysms: A Systematic Review and Meta-Analysis;World Neurosurgery;2024-04
2. Ticagrelor versus clopidogrel dual antiplatelet therapy for unruptured intracranial aneurysms treated with flowdiverter;Journal of Neuroradiology;2023-05
3. Clinical and Pre-Clinical Pharmacokinetics and Pharmacodynamics of Bentracimab;Clinical Pharmacokinetics;2023-04-28
4. Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding;European Heart Journal;2023-03-29
5. Reversal of Platelet Inhibition in Patients Receiving Ticagrelor;Reviews in Cardiovascular Medicine;2022-09-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3